abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Operating Expenses
-$20.39M
Quarterly · Period ending: · USD
HQL Operating Expenses
Latest reported-$20.39Mperiod ending
Latest reported-$20.39Mperiod ending
HQL Quarterly Operating Expenses ($145.00K → -$20.39M)
Quarterly operating expenses
High-resolution chart · PNG
HQL operating expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| -20,386,819 | |
| -123,638,857 | |
| 62,906,159 | |
| 3,181,733 | |
| 2,718,600 | |
| 38,421,476 | |
| 2,870,019 | |
| 14,945,251 | |
| 38,865 | |
| 15,902 | |
| 15,219 | |
| 45,824 | |
| 14,005 | |
| 2,631,170 | |
| 2,688,454 | |
| 2,815,402 | |
| 2,777,532 | |
| 40,874 | |
| 25,998 | |
| 56,658 | |
| 70,006 | |
| 51,390 | |
| 90,566 | |
| 53,368 | |
| 35,020 | |
| 58,400 | |
| 12,863 | |
| 21,713,430 | |
| 53,772,167 | |
| 675,000 | |
| 675,000 | |
| 395,000 | |
| 395,000 | |
| 380,000 | |
| 380,000 | |
| 410,000 | |
| 410,000 | |
| 485,000 | |
| 485,000 | |
| 355,000 | |
| 355,000 | |
| 330,000 | |
| 330,000 | |
| 305,000 | |
| 305,000 | |
| 255,000 | |
| 255,000 | |
| 295,000 | |
| 295,000 | |
| 225,000 | |
| 225,000 | |
| 120,000 | |
| 120,000 | |
| 115,000 | |
| 115,000 | |
| 145,000 | |
| 145,000 |